SEP
12
A vaccine is developed for cancer using covid vaccine technology

An anti-cancer vaccine has been developed in Europe using covid anti-injection technology.
The anti-cancer vaccine was developed by AstraZeneca using the same virus vector as the covid vaccine.
Researchers at the University of Oxford are set to begin a clinical trial of the vaccine.
638 Views
Comments